Neko Health raises $700 million for expansion and clinic profitability
Swedish health tech company Neko Health has secured $700 million in Series C funding, aiming to expand its services and develop proactive healthcare. The company also announced it has achieved profitability at the clinic level.
Swedish health tech startup Neko Health announced on July 15, 2026, that it has raised $700 million in a Series C funding round. The investment was led by General Catalyst, with participation from existing investors Costanoa Ventures, EQT Ventures, and VEGFR. The capital infusion is intended to fuel the company's expansion and further development of its proactive healthcare model.
Neko Health focuses on providing personalized health scans and screenings designed to identify health risks at an early stage. CEO Hjalmar Nilsonne stated that the company is now profitable on a clinic-by-clinic basis and serves 100,000 members. "We have demonstrated that we can build a profitable business in proactive healthcare. Our goal is to shift the healthcare paradigm from being reactive to proactive," Nilsonne said.
The newly acquired funds will be used to expand Neko Health's international presence and enhance its technological capabilities. The company has recently opened a new clinic in Stockholm and plans further European openings. This expansion comes amid a growing global market for preventative health technologies, driven by an increasing consumer focus on long-term well-being.
The company's business model relies on a membership structure, granting access to comprehensive health assessments and personalized health plans. Neko Health suggests its approach can lead to long-term cost reductions in healthcare systems through early detection and preventative interventions, contributing to a more efficient and effective health service delivery.